再生医学：潜力与前景、陷阱与挑战。
Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.
机构信息
Brigham and Women's Hospital Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
出版信息
Eur J Clin Invest. 2012 Aug;42(8):900-13. doi: 10.1111/j.1365-2362.2012.02667.x. Epub 2012 Mar 21.
Abstract
BACKGROUND
Chronic lung diseases contribute significantly to the morbidity and mortality of the population. There are few effective treatments for many chronic lung diseases, and even fewer therapies that can arrest or reverse the progress of the disease.
DESIGN
In this review, we present the current state of regenerative therapies for the treatment of chronic lung diseases. We focus on endothelial progenitor cells, mesenchymal stem cells, and endogenous lung stem/progenitor cells; summarize the work to date in models of lung diseases for each of these therapies; and consider their potential benefits and risks as viable therapies for patients with lung diseases.
CONCLUSIONS
Cell-based regenerative therapies for lung diseases offer great promise, with preclinical studies suggesting that the next decade should provide the evidence necessary for their ultimate application to our therapeutic armamentarium.
摘要
背景
慢性肺部疾病是导致人群发病率和死亡率的主要原因。对于许多慢性肺部疾病，目前几乎没有有效的治疗方法，能够阻止或逆转疾病进展的疗法更是少之又少。
设计
在这篇综述中，我们介绍了治疗慢性肺部疾病的再生疗法的最新进展。我们重点介绍内皮祖细胞、间充质干细胞和内源性肺干细胞/祖细胞；总结了目前为止针对这些疗法的肺部疾病模型中的工作；并考虑了它们作为肺部疾病患者可行治疗方法的潜在益处和风险。
结论
基于细胞的肺部疾病再生疗法前景广阔，临床前研究表明，未来十年应该提供必要的证据，最终将其应用于我们的治疗武器库中。
相似文献
1
Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.再生医学：潜力与前景、陷阱与挑战。
Eur J Clin Invest. 2012 Aug;42(8):900-13. doi: 10.1111/j.1365-2362.2012.02667.x. Epub 2012 Mar 21.
2
Concise review: current status of stem cells and regenerative medicine in lung biology and diseases.简明综述：干细胞与再生医学在肺生物学及疾病中的现状
Stem Cells. 2014 Jan;32(1):16-25. doi: 10.1002/stem.1506.
3
Endogenous lung stem cells: what is their potential for use in regenerative medicine?内源性肺干细胞：它们在再生医学中的应用潜力如何？
Expert Rev Respir Med. 2010 Jun;4(3):349-62. doi: 10.1586/ers.10.21.
4
Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking.脂肪干细胞治疗可减轻吸烟诱导的小鼠肺部和全身损伤。
Am J Respir Crit Care Med. 2011 Jan 15;183(2):215-25. doi: 10.1164/rccm.201001-0126OC. Epub 2010 Aug 13.
5
Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.将基础研究转化为安全有效的基于细胞的呼吸疾病治疗方法。
Ann Am Thorac Soc. 2019 Jun;16(6):657-668. doi: 10.1513/AnnalsATS.201812-890CME.
6
Lung stem and progenitor cells.肺干/祖细胞。
Respiration. 2013;85(2):89-95. doi: 10.1159/000346500. Epub 2013 Feb 11.
7
Cell-based therapy in lung regenerative medicine.肺再生医学中的细胞疗法。
Regen Med Res. 2014 Apr 11;2(1):7. doi: 10.1186/2050-490X-2-7. eCollection 2014 Dec.
8
Stem cell biology and regenerative medicine for neonatal lung diseases.干细胞生物学和再生医学在新生儿肺部疾病中的应用。
Pediatr Res. 2018 Jan;83(1-2):291-297. doi: 10.1038/pr.2017.232. Epub 2017 Oct 18.
9
Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.祖细胞内皮细胞在心血管疾病及新兴治疗方法中的作用。
Catheter Cardiovasc Interv. 2007 Oct 1;70(4):477-84. doi: 10.1002/ccd.21292.
10
Stem cells in kidney diseases.肾脏疾病中的干细胞。
J Stem Cells. 2012;7(4):245-59.
引用本文的文献
1
The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease.先天性心脏病患儿中内皮祖细胞与肺动脉高压的关系
BMC Pediatr. 2019 Dec 17;19(1):502. doi: 10.1186/s12887-019-1884-x.
2
Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?慢性阻塞性肺疾病中的干细胞治疗。距离临床应用还有多远？
Am J Stem Cells. 2018 Aug 1;7(3):56-71. eCollection 2018.
3
Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis.脂肪干细胞条件培养基对肺动脉高压和肺纤维化的治疗潜力
Br J Pharmacol. 2016 Oct;173(19):2859-79. doi: 10.1111/bph.13562. Epub 2016 Aug 26.
4
Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways.衰老与肺部疾病。临床影响以及细胞和分子途径。
Ann Am Thorac Soc. 2015 Dec;12(12):S222-7. doi: 10.1513/AnnalsATS.201508-484PL.
5
MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension.微小RNA与间充质干细胞：肺动脉高压的希望
Rev Bras Cir Cardiovasc. 2015 Jul-Sep;30(3):380-5. doi: 10.5935/1678-9741.20150033.
6
Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series).肺动脉高压的干细胞和祖细胞治疗：对右心室的影响（2013 年 Grover 会议系列）。
Pulm Circ. 2015 Mar;5(1):73-80. doi: 10.1086/679701.
7
Cell-based therapy in lung regenerative medicine.肺再生医学中的细胞疗法。
Regen Med Res. 2014 Apr 11;2(1):7. doi: 10.1186/2050-490X-2-7. eCollection 2014 Dec.
8
Ethics and policy issues for stem cell research and pulmonary medicine.干细胞研究与肺病医学的伦理及政策问题
Chest. 2015 Mar;147(3):824-834. doi: 10.1378/chest.14-1696.
9
Bone marrow-derived multipotent stromal cells attenuate inflammation in obliterative airway disease in mouse tracheal allografts.骨髓来源的多能基质细胞减轻小鼠气管同种异体移植闭塞性气道疾病中的炎症。
Stem Cells Int. 2014;2014:468927. doi: 10.1155/2014/468927. Epub 2014 Sep 10.
10
Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.干细胞、细胞疗法和生物工程在肺生物学和疾病中的应用。对 2010-2012 年近期文献的综合回顾。
Ann Am Thorac Soc. 2013 Oct;10(5):S45-97. doi: 10.1513/AnnalsATS.201304-090AW.
本文引用的文献
1
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.缺血性心肌病患者的心脏干细胞（SCIPIO）：一项随机 1 期试验的初步结果。
Lancet. 2011 Nov 26;378(9806):1847-57. doi: 10.1016/S0140-6736(11)61590-0. Epub 2011 Nov 14.
2
The haematopoietic stem cell niche at a glance.造血干细胞龛概览。
J Cell Sci. 2011 Nov 1;124(Pt 21):3529-35. doi: 10.1242/jcs.074112.
3
Cell-based therapies for lung vascular diseases: lessons for the future.基于细胞的肺血管疾病治疗策略：对未来的启示。
Proc Am Thorac Soc. 2011 Nov;8(6):535-40. doi: 10.1513/pats.201105-035MW.
4
Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection.远端气道干细胞在体外产生肺泡，并在 H1N1 流感感染后肺再生期间产生肺泡。
Cell. 2011 Oct 28;147(3):525-38. doi: 10.1016/j.cell.2011.10.001.
5
A breath of fresh air in lung regeneration.肺部再生领域的新突破。
Cell. 2011 Oct 28;147(3):485-7. doi: 10.1016/j.cell.2011.10.008.
6
Lung stem cells--from an evolving understanding to a paradigm shift?肺干细胞——从不断发展的认识到范式转变？
Stem Cell Res Ther. 2011 Oct 20;2(5):41. doi: 10.1186/scrt82.
7
The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011.国际心肺移植学会登记处：第28份成人肺移植和心肺联合移植报告——2011年
J Heart Lung Transplant. 2011 Oct;30(10):1104-22. doi: 10.1016/j.healun.2011.08.004.
8
Tissue-specific adult stem cells in the human lung.人类肺部的组织特异性成体干细胞。
Nat Med. 2011 Sep 7;17(9):1038-9. doi: 10.1038/nm.2463.
9
Lung stem cell self-renewal relies on BMI1-dependent control of expression at imprinted loci.肺干细胞自我更新依赖于 BMI1 依赖性控制印迹基因座的表达。
Cell Stem Cell. 2011 Sep 2;9(3):272-81. doi: 10.1016/j.stem.2011.07.007.
10
Bronchiolitis obliterans syndrome: the final frontier for lung transplantation.闭塞性细支气管炎综合征：肺移植的最后边界。
Chest. 2011 Aug;140(2):502-508. doi: 10.1378/chest.10-2838.
Zotero 插件